Glaxo Claims OTC Switch Dominance With An Eye Toward Xenical In 2006

GlaxoSmithKline believes an OTC switch of the prescription weight-loss drug Xenical (orlistat) could have the same success as its nonprescription nicotine replacement therapy offerings